NYSE : MDT
Medtronic plc — Key statistics
Healthcare · Medical Devices · Ireland
Last price 96.54 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 118.18B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 118.74B |
| Enterprise Value | 137.91B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | Sep 25, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.22B |
| Shares Outstanding | 1.22B |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 91.20% |
| Float | 1.22B |
Ratios
| Measure | Value |
|---|
| PE Ratio | 23.89 |
| Forward PE | 16.14 |
| PS Ratio | 3.15 |
| Forward PS | 3.02 |
| PB Ratio | 2.46 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.27 |
| P/OCF Ratio | 14.71 |
| PEG Ratio | 3.27 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 26.26 |
| EV / Sales | 3.66 |
| EV / EBITDA | 13.20 |
| EV / EBIT | 18.20 |
| EV / FCF | 22.40 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.07 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 2.63 |
| Debt / FCF | 4.59 |
| Interest Coverage | 10.41 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.65% |
| Return on Assets (ROA) | 5.12% |
| Return on Invested Capital (ROIC) | 8.59% |
| Return on Capital Employed (ROCE) | 9.26% |
| Weighted Average Cost of Capital (WACC) | 6.35% |
| Revenue Per Employee | $395,179 |
| Profits Per Employee | $55,063 |
| Employee Count | 95,000 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.15 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.33B |
| Effective Tax Rate | 20.19% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +5.24% |
| 50-Day Moving Average | 91.70 |
| 200-Day Moving Average | 88.16 |
| Relative Strength Index (RSI) | 60.54 |
| Average Volume (20 Days) | 28,621,184 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 139.00M |
| Short Previous Month | 17.23M |
| Short % of Shares Out | 11.36% |
| Short % of Float | 11.38% |
| Short Ratio (days to cover) | 4.63 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 37.54B |
| Gross Profit | 24.50B |
| Operating Income | 7.55B |
| Pretax Income | 6.60B |
| Net Income | 5.23B |
| EBITDA | 10.41B |
| EBIT | 7.55B |
| Earnings Per Share (EPS) | $4.06 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 8.82B |
| Total Debt | 28.15B |
| Net Cash | -19.17B |
| Net Cash Per Share | -$15.66 |
| Equity (Book Value) | 50.85B |
| Book Value Per Share | 39.24 |
| Working Capital | 12.59B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 8.04B |
| Capital Expenditures | -1.90B |
| Depreciation & Amortization | 2.86B |
| Net Borrowing | 151.00M |
| Free Cash Flow | 6.13B |
| FCF Per Share | $5.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | 65.27% |
| Operating Margin | 20.10% |
| Pretax Margin | 17.59% |
| Profit Margin | 13.93% |
| EBITDA Margin | 27.72% |
| EBIT Margin | 20.10% |
| FCF Margin | 16.33% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.88 |
| Dividend Yield | 2.97% |
| Dividend Growth (YoY) | 1.42% |
| Years of Dividend Growth | 50 |
| Payout Ratio | 70.94% |
| FCF Payout Ratio | 57.49% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 2.98% |
| Earnings Yield | 4.19% |
| FCF Yield | 5.19% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $104.62 |
| Price Target Difference | 7.86% |
| Analyst Consensus | Buy |
| Analyst Count | 30 |
| Revenue Growth Forecast (3Y) | 5.20% |
| EPS Growth Forecast (3Y) | 7.71% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |